- About Us
- Advertise
- Contact Us
- Editorial Info
- Editorial Advisory Board
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2025 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
Featured Content
European Biotech Targeting Anti-ageing
Oct 2nd 2024
Novel mitophagy inducers and gene therapies that restore cellular function and decelerate the ageing process.
Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?
Mar 4th 2024
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Training for Operational Excellence
Dec 3rd 2023
The bio/pharmaceutical industry is struggling with the challenge of staffing and training.
Billions of Reasons to be Buoyant
Sep 2nd 2023
Pharma's ability to continually reinvent itself will be critical in growing future business operations.
Latest Videos
Latest News
mRNA Global Alliance Tests the Waters at BIO
June 12th 2023
World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration.
Biosimilar CDMO Capacity Increased in Samsung Biologics – Pfizer’s New Arrangement
June 8th 2023
The collaboration between Samsung Biologics and Pfizer will focus on long-term biosimilars manufacturing.
Merck Files Lawsuit Against US Government
June 8th 2023
The complaint alleges that Medicaid price controls implemented in the Inflation Reduction Act will negatively impact biopharmaceutical innovation.
Sartorius and Waters Expand Analytics Collaboration
June 8th 2023
Sartorius and Waters will collaborate to develop integrated analytical solutions for downstream biomanufacturing.
Aragen Life Sciences and FAR Biotech Enter Neurodegeneration Collaboration
May 30th 2023
Aragen and FAR Biotech will collaborate to advance a small-molecule neurodegeneration program.
Novartis Purchases Cystinosis Gene Therapy from AVROBIO
May 30th 2023
The $87.5 million purchase grants Novartis rights to an investigational gene therapy program intended for treatment of cystinosis.
Ironwood Inks $1 Billion Deal to Acquire VectivBio
May 24th 2023
Ironwood Pharmaceuticals’ acquisition of VectivBio grants it the rights to apraglutide, a glucagon-like peptide being evaluated for gastrointestinal diseases.
Astellas and Sony Enter ADC Platform Collaboration
May 17th 2023
Astellas and Sony will collaborate to discover a novel ADC platform for use in oncology.
%20(1).webp?w=350&fit=crop&auto=format)
FTC Sues to Block Amgen’s $27.8 Billion Acquisition of Horizon Therapeutics
May 16th 2023
In a brief, the Federal Trade Commission cited concerns about the acquisition resulting in an increased monopoly on Amgen’s newly acquired thyroid eye disease and chronic refractory gout treatments.
Bright Path Laboratories to Collaborate in NSF Engines Development Program
May 16th 2023
The NSF-sponsored program aims to help partners collaborate to create opportunities for significant economic, societal, and technological opportunities for growth in their regions.